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Genes encoded by mitochondrial DNA (mtDNA) exist in large
numbers per cell but can be selected very rapidly as a result of
unequal partitioning of mtDNA between germ cells during embry-
ogenesis. However, empirical studies of this ‘‘bottlenecking’’ effect
are rare because of the apparent scarcity of heteroplasmic indi-
viduals possessing more than one mtDNA haplotype. Here, we
report an example of insecticide resistance in an arthropod pest
(Tetranychus urticae) being controlled by mtDNA and on its inher-
itance in a heteroplasmic mite strain. Resistance to the insecticide
bifenazate is highly correlated with remarkable mutations in
cytochrome b, a mitochondrially encoded protein in the respiratory
pathway. Four sites in the Qo site that are absolutely conserved
across fungi, protozoa, plants, and animals are mutated in resistant
mite strains. Despite the unusual nature of these mutations,
resistant mites showed no fitness costs in the absence of insecti-
cide. Partially resistant strains, consisting of heteroplasmic indi-
viduals, transmit their resistant and susceptible haplotypes to
progeny in highly variable ratios consistent with a sampling
bottleneck of 180 copies. Insecticide selection on heteroplasmic
individuals favors those carrying resistant haplotypes at a fre-
quency of 60% or more. This combination of factors enables very
rapid evolution and accounts for mutations being fixed in most
field-collected resistant strains. The results provide a rare insight
into non-Mendelian mechanisms of mitochondrial inheritance and
evolution, relevant to anticipating and understanding the devel-
opment of other mitochondrially encoded adaptations in arthro-
pods. They also provide strong evidence of cytochrome b being the
target site for bifenazate in spider mites.
bifenazate  Tetranychus urticae  cytochrome b  mtDNA
Compared with cell nuclei, mitochondria contain few genes,but they exhibit some intriguing evolutionary characteristics.
Their inheritance is essentially non-Mendelian in that recombi-
nation through meiosis is lacking and transmission to offspring
is predominantly uniparental. In contrast to nuclear DNA, in
which there are only two copies of each gene per cell, the
mitochondrial DNA (mtDNA) copy number in somatic cells is
generally in the range of 103–104 copies per cell (1). Higher
mutation rates in animal mtDNA together with limited DNA
repair mechanisms render these genes susceptible to rapid
evolution through random drift or natural selection. As a
consequence, mtDNA is highly polymorphic and is widely used
for studies in systematics and population genetics. However,
most genetic variation within a species exists between individ-
uals, and the occurrence of more than one mtDNA sequence
variant in a single individual (heteroplasmy) is relatively rare (2).
Empirical work has shown that genotype frequencies in hetero-
plasmic individuals can shift greatly in a single transmission from
mother to offspring, a phenomenon that has been ascribed to
‘‘genetic bottlenecking’’ caused by selective replication of DNA
templates or unequal partitioning of mtDNA between germ cells
during embryogenesis (2–4). As a result of these characteristics,
traits encoded by mtDNA have the potential to evolve, and reach
fixation, very rapidly. We report here on a case of insecticide
resistance encoded by mtDNA in which the occurrence of
heteroplasmy has disclosed relationships between intracellular
genetic variation and inheritance of the resistance phenotype, a
rare example of non-Mendelian inheritance in action.
The ability of arthropods to develop insecticide resistance has
led in extreme cases to catastrophic crop failures or resurgence
of vector-borne diseases. Considerable progress has been made
with characterizing the underlying mechanisms, including en-
hanced detoxification or structural changes to target-site pro-
teins (5). To date, however, there have been no reports of
resistance encoded by mtDNA in arthropods. Several insecti-
cides do target biochemical processes in mitochondria, but cases
of resistance resolved so far have involved mutations in the
nuclear genome. A possible example of mtDNA-controlled
resistance arose from work involving the insecticide bifenazate
and the two-spotted spider mite, Tetranychus urticae Koch. T.
urticae is a cosmopolitan and polyphagous crop pest with a long
history of developing resistance to pesticides (6). Bifenazate is a
member of the new insecticidal group of hydrazine carbazate
derivatives, whose mode of action has so far been unknown.
Selection of T. urticae with bifenazate in the laboratory gener-
ated 100,000-fold resistance (7). Of particular note, reciprocal
crosses between susceptible and resistant mites showed resis-
tance to be inherited only maternally; offspring of resistant
females were strongly resistant, but those of susceptible females
remained fully susceptible. Such complete uniparental inheri-
tance is unprecedented for insecticide resistance and suggested
mitochondrial control as one possible explanation.
Results
Amplification of Whole Mitochondrial Genomes and Identification of
Putative Resistance-Conferring Mutations. We amplified, se-
quenced, and compared complete mitochondrial genomes of
susceptible and resistant strains of T. urticae (GenBank
EU345430, susceptible strain). Despite being one of the most
compact mitochondrial genomes (13,103 bp), all 13 protein-
encoding genes expected in animal mitochondrial genomes and
genes coding for S12 and S16 ribosomal RNA were represented
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(Fig. 1A). A comparison of the complete genomic sequences of
the laboratory-selected bifenazate-resistant strain (GenBank
accession no. EU5567754, BR-VL) with that of the original
unselected strain (LS-VL) showed only three nucleotide substi-
tutions, all nonsynonymous, in the cytochrome b (cytb) gene,
resulting in amino acid substitutions G126S, S141F, and D161G
(Fig. 1B and Table 1). Cytochrome b is the only mitochondrially
encoded component of the ubihydroquinone:cytochrome c ox-
idoreductase (cytochrome bc1, complex III) that catalyzes elec-
tron transfer from reduced ubiquinone to cytochrome c, coupled
to proton translocation across the membrane. Comparison of
cytb alignment of translated sequences from the susceptible and
laboratory-resistant strains with those from several model or-
ganisms showed that these mutations were located in the Qo
oxidation site of the protein, more precisely in the cd1 helix
aligning the enzyme pocket (8).
Amplification of cytb from Collected Field Strains. To reinforce the
likelihood of these mutations being implicated in resistance, we
sequenced and assayed several field strains of T. urticae from
regions in The Netherlands where loss of susceptibility to
bifenazate was observed. Three more strains (HOL1, HOL2, and
HOL4) contained the G126S mutation found in the laboratory-
selected strain. In two strains (HOL1 and HOL4) this mutation
was accompanied by a second I136T mutation, also located in
the cd1 helix of the Qo pocket (Fig. 1B and Table 1). Combi-
nation of these mutations gave extreme resistance to bifenazate
(Table 1). Interestingly, the strain with G126S alone (HOL2)
showed only low resistance to bifenazate (Table 1), suggesting
Fig. 1. Cytb resistance mutations in the mitochondrial genome. (A) Linear representation of the mitochondrial genome of T. urticae (13,103 bp) showing the
position and orientation of the protein-encoding genes (n  13) and the ribosomal RNA genes (n  2). (B) Sequence alignment of conserved Qo pocket residues
positioned on the cytochrome b of T. urticae with those of S. cerevisiae (ABS28693), P. falciparum (NP059668), Venturia inaequalis (AAC03553), Arabidopsis
thaliana (CAA47966), Drosophila melanogaster (CAB91062), Gallus gallus (AAO44995), and Homo sapiens (AAX15094). Fully conserved residues in the alignment
are marked in black. Point mutations linked to bifenazate resistance in T. urticae are indicated by triangles.
Table 1. Relationship between genotype (cytb sequence) and bifenazate susceptibility for laboratory and field-derived strains
of T. urticae
Strain Accession no. Origin Cytb genotype,* protein/gene
LC50 bifenazate, mg a.i. per liter
(95% fiducial limits)
LS-VL EU345430 Laboratory, susceptible WT/WT 1.6 (1.5–1.7)
GSS EU556751 Laboratory, susceptible WT/WT 3.6 (3.3–3.9)
MR-VL EU556752 Ghent, Belgium WT/WT 10.5 (9.7–11.3)
MR-VP EU556753 Brussels, Belgium WT/WT 7.3 (5.6–9.4)
BR-VL EU556754 Selected from LS-VL G126S/G376A S141F/C422T 10,000
HOL1 EU556747 Hoek van Holland, The Netherlands G126S/G376A I136T/T407C 10,000
HOL 2 EU556748 Hoek van Holland, The Netherlands G126S/G376A 43.4† (38.1–49.7)
HOL3 EU556749 Nieuwveen, The Netherlands P262T/C784A 10,000‡
HOL4 EU556750 Tuil, The Netherlands G126S/G376A I136T/T407C 10,000
a.i., active ingredient.
*WT, wild-type sequence corresponding to the alignment in the bottom row of Fig 1B.
†Mixed strain with individuals fixed for G126S or WT. Mites surviving 50 mg of a.i. per liter of bifenazate consistently had the G126S genotype.
‡After fixation of the mutation through laboratory selection. The initial LC50 after collection was 72 mg of a.i. per liter (fiducial limits: 64–82).



































that a combination of at least two cd1 helix mutations (G126S
and I136T in HOL1 and HOL4, or G126S and S141F in BR-VL)
is necessary to confer a pronounced resistance phenotype. The
third D161G mutation in BR-VL was located at a less conserved
position not in contact with the Qo pocket, and it is not clear
whether this mutation is directly implicated in resistance. We
also identified a field strain (HOL3) with a new mutation: a
P262T substitution in the highly conserved PEWY motif at the
ef helix aligning the Qo pocket of cytb (Fig. 1B). This mutation
was the only one detected in HOL3, which again exhibited at
least 10,000-fold resistance to bifenazate. Other field and labo-
ratory strains with a wild-type cytb sequence in the cd1 and ef
helix positions showed no resistance to bifenazate. Collectively,
these findings implicate bifenazate (when applied against spider
mites) as a Qo site inhibitor, whose activity can be severely
compromised by mutations at the binding site.
Mitochondrial Heteroplasmy and Inheritance. In the first strain to be
characterized (BR-VL), mutations conferring bifenazate resis-
tance were ubiquitous, and no heteroplasmy was observed.
However, the emergence of any new mtDNA haplotype implies
a mutation in one female germ line cell and an intermediate
heteroplasmic stage must follow. Under sustained selection, this
stage may be of short duration because of rapid and unequal
segregation of mitochondria in the female germ line or early
embryo (the genetic bottleneck effect) (2). Thus, all subsequent
field strains were carefully scrutinized for the occurrence of
heteroplasmy and one such strain (HOL3) with the PEWY motif
P262T mutation (Table 1) was identified. This strain had been
collected in a glasshouse with a history of bifenazate treatment.
The P262T mutation results from a C to A nucleotide substitu-
tion at position 784 in cytb. Heteroplasmy was suspected from a
double peak at position 784 when analyzing a pooled sample of
100 mites with sequencing chromatographs. We subsequently
amplified and investigated the complete cytb sequence of 26
individual mites and quantified the frequency of susceptible and
resistant haplotypes as the relative peak heights at position 784
on chromatographs. The frequency of the mutation in these
individuals varied in a continuous manner from 30 to 98% (Fig.
2A). The implications for inheritance were investigated by
breeding offspring from five randomly selected females whose
frequency of the C784A nucleotide substitution proved to be 37,
53, 68, 81, and 96% (Fig. 2 B–F). The first eight female offspring
of each mother that reached adulthood were also analyzed for
heteroplasmy, and a clear parent– offspring relationship
emerged (Fig. 2 B–F). However, frequencies of the resistant
haplotype in offspring varied substantially around the parental
values with, for example, progeny of a mother with a 37% mutant
frequency showing corresponding frequencies of 5–58% (Fig.
2B). Variation between progeny of a mother with 96% mutant
haplotypes (i.e., approaching fixation for the resistance muta-
tion) was much more limited, and in this case the mutation was
transmitted more faithfully from parent to offspring (Fig. 2F).
Establishing a Mutation Threshold for Phenotypic Expression of Re-
sistance. We divided mites of the heteroplasmic HOL3 strain into
two groups: mites paralyzed at 100 mg/liter (equivalent to the
field rate of bifenazate) and mites not paralyzed by this concen-
tration of bifenazate. Paralyzed mites had an average percentage
mutation of 55% (SE  9, n  10) and resistant mites 86% (SE 
5, n  8). Mites surviving the field dose had a percentage
mutation of at least 60%, defining a discriminating boundary for
survival. We also tested third-generation offspring of single
mothers with different initial mutation frequencies for toxicity at
100 mg/liter (Fig. 3), again revealing a threshold mutation
frequency of 60% to result in field resistance.
Modeling the Inheritance of Heteroplasmy. By using the observed
variance distributions for progeny, it is possible to estimate the
magnitude of random processes influencing the segregation and
partitioning of mitochondria during reproduction and embryo-
genesis (2, 9 and see Materials and Methods). The key parameter
Fig. 2. Inheritance of mtDNA heteroplasmy for the P262T mutation in the HOL3 strain of T. urticae. Frequencies of resistant haplotypes are shown as
corresponding relative peak heights of nucleotides on forward and reverse strands. (A) Frequency of resistant haplotypes in 25 randomly selected individual mites
on collection from the field. (B–F) Frequency of resistant haplotypes in single mothers (shown by arrows) and in eight of their first-generation offspring. Dotted
lines show the estimated mutation frequency (60%) needed to survive field-applied concentrations of bifenazate.






















for estimation is Ne, the effective number of mtDNAs sampled
at each generation from the very large pool potentially available.
Estimates of Ne based on examples of heteroplasmic inheritance
shown in Fig. 2 (and assuming k  10; see Material and Methods)
ranged from 79 to 263, with a median value of 181 (Table 2). This
figure is broadly in line with those from studies of mice and
Drosophila (2, 9) and represents only a small proportion of the
total number of mtDNA molecules likely to occur in mature
oocytes (1). The influence of random drift on changes in
mutation frequency between generations can be appreciated
most clearly by examining the relationship between frequency of
the resistant haplotype and expression of a bifenazate resistance
phenotype. Although one would expect a continuous relation-
ship between the frequency of mtDNA mutations and absolute
levels of resistance, selection will only occur when the latter is
sufficient to withstand concentrations of insecticide that mites
encounter under field conditions. As described above, an ap-
proximate threshold of 60% mutated mtDNA is required to
avoid symptoms of paralysis with the field application rate of
bifenazate. It is notable that even the mother exhibiting lowest
frequency of the resistant haplotype (37%; Fig. 2B) in the
inheritance experiment produced progeny (one of eight) around
this 60% criterion. However, this criterion for selection is
undoubtedly too stringent. It equates to the highest concentra-
tion that mites are likely to encounter, but in practice they will
also encounter insecticide concentrations far lower than the field
rate as a result of uneven coverage or the decay of residues over
time. Much lower mutation frequencies can therefore confer
advantages and result in selection under field conditions. Thus,
a combination of heteroplasmy, genetic bottlenecking, and sus-
tained selection can lead quickly to the emergence of a resistance
phenotype and drive populations rapidly toward fixation of the
advantageous trait, which is consistent with observations that all
other bifenazate-resistant strains investigated so far have been
homoplasmic for mutations conferring resistance.
Effects on Overall Fitness. As well as facilitating the selection of
resistance mutations, processes operating during mitochondrial
inheritance could also speed up their loss if they confer fitness
costs in the absence of the selecting agent. Given the extent to
which the sites containing the cytb mutations in T. urticae are
strongly conserved in nature (Fig. 1B), a reasonable a priori
expectation is that these mutations will have implications for the
fitness of their carriers. This expectation is supported by studies
investigating the effect of induced cytb mutations on respiratory
function in model organisms such as the yeast Saccharomyces
cerevisiae. Substitutions at the G137 site in S. cerevisiae (equiv-
alent to G126 in T. urticae) were found to impair respiratory
competence by uncoupling the complex and affecting FeS
stability (10, 11). Substitutions at I147 (equivalent to I136 in T.
urticae) were also shown to affect respiratory competence re-
flected by reduced cytochrome c reductase activity (12). We
compared the overall biological fitness of the laboratory-selected
BR-VL strain of T. urticae with that of the susceptible LS-VL
strain by measuring a series of life history traits including
fecundity, longevity, and development time, by calculating a
composite demographic parameter (intrinsic rate of increase or
rm; Table 3). There were no significant differences in individual
parameters or in estimates of rm, implying that resistant mites can
survive and reproduce as efficiently as susceptible ones in the
absence of exposure to bifenazate.
Discussion
Resolution of the mitochondrial target site of bifenazate and
confirmation that resistance is mitochondrially encoded and
inherited has provided rare experimental insights into the dif-
ferent evolutionary dynamics of mtDNA genes and those in the
nuclear genome. There are interesting parallels with cases of Qo
site inhibitor resistance reported in various crop and human
pathogens. Resistance to strobilurin fungicides, which block
electron transfer at the Qo site, in field isolates of fungal
pathogens is correlated with principally two mutations: G143A
and F129L in the cd1 helix of cytb (13). G143A is the more
common mutation, and isolates carrying this mutation express
very strong resistance to strobilurins. Cases of strobilurin resis-
tance, as in Mycosphaerella graminicola (the cause of septoria
leaf blotch disease in wheat), have also emerged extremely
rapidly, and examples of isolates showing heteroplasmy have
proved extremely rare in the field (13–15). As is the case with T.
urticae, mutations conferring strobilurin resistance have gener-
ally had no adverse effects on overall fitness (13). Atovaquone,
a well known Qo inhibitor, was recently introduced as a clinical
antimalarial in combination with proguanil. Where atovaquone
Table 2. Distribution of mitochondrial genotypes in the progeny of four founder
heteroplasmic female mites and the effective number of segregating mtDNA units
po  102 N pn  102 Range Vn  104
Ne
k  8 k  10 k  12 k  14 k  16
37 8 36 (5–58) 296 63 79 95 1,104 126
53 8 53 (29–69) 166 117 146 175 204 233
68 8 71 (51–80) 90 190 237 285 332 379
81 8 73 (62–87) 58 210 263 315 367 420
po, frequency of the resistant haplotype in the founder female; n, number of offspring tested; pn, average
frequency of the resistant haplotype in offspring; Vn, variance of frequency in offspring; Ne, number of effective
segregating units for mtDNA; k, number of cell divisions.
Fig. 3. Establishing a link between phenotype and genotype. The relation-
ship between frequency of the resistant haplotype in single founder females
from the HOL3 strain of T. urticae and susceptibility of third-generation
siblings to 100 mg of active ingredient (a.i.) per liter of bifenazate is shown.



































has been used in monotherapy in clinical trials, resistance also
emerged extremely rapidly linked to point mutations affecting
Y268 in the ef helix of Plasmodium falciparum (16).
More speculatively, the rate at which Qo inhibitor resistance
develops may also be accelerated by an increased mutation rate.
It is known that the lack of histones and repair mechanisms in
mtDNA, together with its close proximity to the electron trans-
port chain, leads to an elevated rate of mtDNA damage. Damage
and thus mutagenesis of mtDNA are affected by the oxidation
of nucleotides by reactive oxygen species (ROS), leading to a
mispairing event during replication (17). The concentration of
ROS is known to increase under the action of Qo site inhibitors,
and this may in turn increase the rate of mutagenic oxidation
(18). Potentially increased mutation rates in response to inhib-
itor action conform to the concept of ‘‘adaptive mutations’’ (19,
20), rather than supporting the model of constant rare mutations
leading to preexisting phenotypes expressing resistance.
Mitochondrial control of resistance, coupled with a lack of
fitness costs, challenges much of the conventional theory of
resistance management, based on Mendelian principles and
exploiting features such as recombination and segregation, the
dominance of resistance alleles, and their dilution through
immigration (21). The speed at which cytb-based resistance has
developed in mites is, in hindsight, explicable through the
idiosyncrasies of mitochondrial evolution and inheritance. It is
likely that Qo site fungicide resistance has arisen in the same
manner. Although mitochondria are considered attractive tar-
gets for unique pesticides, the development and deployment of
such agents without specific information on the target site
evidently require great care.
Materials and Methods
Mite Strains. The original susceptible strain (LS-VL) of T. urticae was collected
in October 2000 from roses near Ghent, Belgium, where pesticides had not
been used for at least 10 years (22). The BR-VL resistant strain was selected
from LS-VL by successively applying bifenazate at concentrations that killed
90% of individuals (7). Other field strains were collected from glasshouses at
different locations in The Netherlands (Table 1). In the laboratory, mites (at
least 500 adult females) were transferred to bean plants (Phaseolus vulgaris L.)
and allowed to reproduce for two to four generations before analysis. All
strains were maintained at 25  0.5°C with 60% relative humidity and a 16/8
h (light/dark) photoperiod.
Bioassays. Bioassays with commercially formulated bifenazate (Floramite, 240
SC) entailed transferring 10–25 young adult female mites to 9-cm2 bean leaf
disks sprayed with 0.6 ml of serial insecticide dilutions (22). Disks were kept at
25  0.5°C, 60% relative humidity, 16/8 h (light/dark) photoperiod on wet
cotton. Mortality was scored after 24 h, and LC50 values and their 95% fiducial
limits were calculated by probit regression by using POLO-PC software (LeOra
Software).
Amplification and Sequencing of Mitochondrial Genomes. Mites were chilled at
4°C for 30 min and gently homogenized in a prechilled (4°C) mortar after
which 10 ml of ice-cold buffer [30 mM TrisHCl, 300 mM sucrose, 10 mM EDTA,
1% BSA (fatty acid-free), pH 7.5] was added. The suspension was centrifuged
for 5 min at 1,000  g at 4°C, and the resulting pellet was homogenized on ice
in 10 volumes of buffer with a Heidolph RZR2020 motorized Teflon pestle for
30 s at 2,000 rpm. The homogenate was filtered through eight layers of
cheesecloth. Mitochondria were isolated by differential centrifugation (3
times 500  g for 5 min, 3 times 1,000  g for 5 min, and 90 s at 1,600  g). Each
time the supernatant was collected. Mitochondria were subsequently pelleted
by centrifugation at 15,000  g for 30 min at 4°C. The crude mitochondrial
pellet was purified on a discontinuous sucrose density gradient (1.5–1.0 M
sucrose in 10 mM TrisHCl, 10 mM EDTA at pH 7.5) by centrifugation for 1 h at
100,000  g at 4°C in a Beckman ultracentrifuge with a SW55i rotor. Purified
mitochondria were lysed in 500 l of SDS buffer (200 mM TrisHCl, 400 mM
NaCl, 10 mM EDTA, 2% SDS at pH 8.2) followed by chloroform–phenol
extraction (23).
The purified circular mtDNA was subsequently used as template for rolling
circle amplification (RCA). RCA was performed with phi29 DNA polymerase
(Fermentas). Reactions were started by mixing 10 l of reaction buffer, 10 l
of 500 M exo-resistant random primers (with two 3-terminal phosphoro-
thioate modifications) (Fermentas), 70 l of sterile double-distilled water, and
10 l of template (1–50 ng of mtDNA). This mixture was denaturated for 3 min
at 95°C followed by slowly cooling down to 20°C, allowing primer binding. A
mix containing 10 l of dNTPs (2 mM each; Invitrogen), 10 l of reaction
buffer, 3 l of yeast pyrophosphatase (0.1 unit/l; Sigma–Aldrich), 5 l of
phi29 (5 units), and 72 l of sterile double-distilled water was subsequently
added. The mixture was briefly vortexed and spun down after which it was
incubated for 18 h at 37°C. Reactions were stopped by heating (5 min, 65°C).
Large DNA fragments were selectively precipitated with 2 volumes of 10%
PEG in 150 mM NaCl (pH 8.0) and resolved in 0.1 M TrisHCl (pH 8.0). RCA-
amplified material was partially sequenced by shotgun sequencing (Agowa
sequencing service). Based on this shotgun library, PCR primers were designed
in the cox1 and cytb gene sequences (C2F, 5-CCAGCTATAATTGGAGGATT-
TGG; C2R, 5-TGTCCTCAAGGTAAAACATACCC; C3F, 5-TGGGTCTCCTCCTC-
CTCTTG; C3R, 5-CCGCTTTTATCGGGTATGTTTTAC) for the amplification of the
complete mitochondrial genome of susceptible and resistant mites in two
overlapping pieces with the Expand Long Range PCR kit (Roche). Resulting
PCR fragments (8 and 6 kb) were sequenced by primer walking on both
strands (Agowa sequencing service).
The complete genomic sequence was assembled and annotated by using
VectorNTI (Invitrogen) according to Masta and Boore (24). ORFs were identi-
fied with the program Getorf from the EMBOSS package. Translated se-
quences were used for Blastp searches against the nonredundant protein
database. Two large non-protein-coding regions were candidates for the
large and small rRNA (16S and 12S, respectively). The boundaries of the rRNA
genes were identified based on alignments and secondary structures of rRNA
genes of other mite species.
Amplification and Sequencing of cytb of Single Mites and Quantification of
Heteroplasmy. Based on the annotated complete mtDNA sequence, primers in
cytb-flanking regions were designed to amplify the complete cytb gene with
Long Range PCR (Cytbdia2F, 5-ATTTGGTTAGATGAGCCTTTTTC; Cytbdia2R,
5-TCATGAAAAAGGCTCATCTAACC) to allow screening for cytb polymor-
phisms in individual mites. Mites were homogenized in 10 l of buffer (10 mM
TrisHCl, 100 mM NaCl, 1 mM EDTA), 2 l of proteinase K (10 mg/ml) was added,
and the mixture was incubated for 30 min at 37°C. After proteinase K activity
was destroyed by heating (5 min at 95°C), 1 l was used as a template for PCR.
The amplified products were purified with a QIAquick PCR purification kit
(Qiagen) and used directly for sequencing using the original PCR primers and
two internal primers (cytbWTF, 5-CGGAATAATTTTACAAATAACTCATGC; cyt-
bWTR, 5-TGGTACAGATCGTAGAATTGCG) so that four times coverage was
obtained for each nucleotide.
For the quantification of heteroplasmy, two primers flanking the 784
position on cytb at equal distance of 200 bp from position 784 were designed
(PEWYF, 5-AAAGGCTCATCTAACCAAATAGG; PEWYR, 5-AATGAAATTTCTG-
TAAAAGGGTATTC). The degree of heteroplasmy was quantified by analyzing
the heights of fluorescence peaks from the electropherogram (Bioedit). The
Table 3. Life table parameters for the susceptible LS-VL and laboratory-selected
bifenazate-resistant BR-VL strains
Parameters LS-VL BR-VL
Female longevity, days 17.51  1.65a 18.95  1.58a
Total fecundity, no. of eggs 105.8  14.21a 125.5  11.53a
Average daily fecundity, eggs per female per day 4.44  0.58a 5.03  0.52a
Generation time T, days 18.72  0.01a 18.72  0.005a
Intrinsic rate of increase, rm, females per female per day 0.209  0.005a 0.205  0.004a
Means (SEM) within rows followed by the same letter are not significantly different (t test, P  0.05).






















proportion A on the forward strand at position 784 in the mixture (%A) was
expressed as the percentage of the A peak height (HA) to the total of the two
peak heights (HA and HB) (%A  HA/(HA  HB)  100). The same procedure
was repeated for T784 on the reverse strand. Average frequencies (estimates
based on both strands) were used for calculations in the model and presen-
tation in Table 2. This way of proportional sequencing gives a high correlation
with proportional data derived from real-time PCR (25).
Determination of Fitness Parameters. Thirty adult females from the susceptible
(LS-VL) and resistant (BR-VL) stock colonies were allowed to lay one egg on a
bean leaf arena (3 cm  3 cm). The arenas were checked every 12 h to track the
development of individual life stages. Mites that died or escaped during the
experiment were omitted from the dataset. For life table analyses, 36 single-
pair matings were established by placing a female in the teleiochrysalis stage
of each strain with a male on a leaf arena. Male and females were transferred
daily to a new arena, and the following parameters were recorded: interval
between the present and previous observation, number of dead or escaped
mites, and number of eggs laid per female. All eggs laid were followed until
reaching adulthood. Experiments were performed at 25  0.5°C, 60% relative
humidity, 16/8 h (light/dark) photoperiod. Based on these data, mean longev-
ity, duration of the oviposition period, and fecundity (expressed as the num-
ber of eggs over the oviposition period) of females were calculated. The
intrinsic rate of increase rm was calculated from the equation e	rmxlx mx  1,
where lx is the proportion of females surviving to age x and mx is the mean
number of female progeny per adult female at age x. Mean generation time
was calculated from the equation [T  ln(lxmx)/rm]. Variance distributions for
rm were calculated by jack-knifing pseudovalues of rm and transferring them
to SPSS 12.0 (SPSS, Inc.) in which independent t tests were used to evaluated
differences between means (26–27).
Modeling the Inheritance of Heteroplasmy. We used a mathematical model
taken from population genetics (2, 9) to investigate the influence of hetero-
plasmy on resistance development in T. urticae. This model uses stochastic
theory to estimate the effective number of mtDNAs (Ne) that are sampled from
a large pool in successive generations, assuming that segregation occurs by
genetic drift. The variance of mtDNA frequencies (Vn) at the nth generation is
given by the following equation:
Vn  p0
1  p01  1  1Ne
kn [1]
in which po is the frequency of the mutated cytb haplotype, Ne is the number
of segregating units taken from a large pool, and k is the number of random
samplings (i.e., cell division number) for every generation. If the variability of
transmission of resistant haplotypes is only dependent on random partition-
ing, the number of segregating units can be inferred from the equation by the
experimentally determined variances, if the number of cell divisions per
generation is known (or can be inferred with sufficient accuracy). However,
the embryology of T. urticae is poorly studied. Approximately 2 h after
oviposition, the embryo undergoes the first total cleavage followed by two
rounds of synchronous divisions leading to the formation of eight equally
sized blastomeres. After this stage, however, cleavages become asynchro-
nous, and cells migrate to the periphery of the embryo (28). In Drosophila,
8–10 divisions take place from egg to stem cells, and assuming k  10 is
probably a good estimate (9). Taking a conservative approach and allowing
k to vary between 8 and 16, and by using data on mutation frequencies
and variances, the median effective number of segregation units (Ne) was
calculated.
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